Boehringer Ingelheim RCV GmbH & Co KG

Form 483 issued December 5, 2023 · Vienna, Austria

Inspection
Nov 29 – Dec 5, 2023
Investigator
Prajakta Varadkar
Observations
2
Pages
2
FEI number
3003433722

In short: On December 5, 2023, FDA issued a Form 483 with 2 observations to Boehringer Ingelheim RCV GmbH & Co KG in Vienna, Austria (FEI 3003433722) after an inspection that ran Nov 29 – Dec 5, 2023. The investigator was Prajakta Varadkar. Most observations concern materials and facilities & equipment; the most-cited regulation is 21 CFR 211.150 (distribution procedures).

At a glance

Materials and facilities & equipment account for 2 of 2 observations.

Materials1
Facilities & equipment1

Most cited: 21 CFR 211.150 (1×) · 211.67 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    SOP for critical steps…

  2. 02

    Equipment preventive maintenance is not adequate…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Boehringer Ingelheim RCV GmbH & Co KG?

FDA listed 2 observations on this Form 483, mostly about materials and facilities & equipment. The most-cited regulation is 21 CFR 211.150 (distribution procedures). The opening words of each observation are shown on this page.

Who inspected Boehringer Ingelheim RCV GmbH & Co KG?

Prajakta Varadkar is named on this Form 483, for the inspection of Nov 29 – Dec 5, 2023. Each investigator has a profile showing what they cite most.

When was Boehringer Ingelheim RCV GmbH & Co KG inspected by FDA?

The inspection ran Nov 29 – Dec 5, 2023, and the Form 483 is dated December 5, 2023.

How do I get the full Form 483 for Boehringer Ingelheim RCV GmbH & Co KG?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free